Helen of Troy (HELE) Q4 2026 earnings review
Sales Stabilize, but Tariffs and Write-Downs Crush the Bottom Line
Helen of Troy's top-line bleeding has slowed, with Q4 sales down just 3.3% YoY—a significant improvement from double-digit drops earlier in the fiscal year. However, the volume stabilization did not save profitability. Tariffs, rising promotional costs, and a massive $79.2M non-cash asset impairment plunged the company into a GAAP net loss of $55.6M. Even on an adjusted basis, EPS collapsed 64% to $0.83. Management's FY27 guidance projects flat revenue and slightly lower earnings, signaling a painful, drawn-out turnaround under new leadership as they battle macro headwinds and pivot to a 'growth-first' strategy.
🐂 Bull Case
Despite deep net losses, Operating Cash Flow surged to $111.3M in Q4. FY26 Free Cash Flow hit $131.9M, giving the company vital liquidity to pay down its $780.8M debt load.
The Olive & June acquisition is providing a critical buffer, adding 3.3% of growth to the Beauty & Wellness segment and masking some of the steeper organic declines.
🐻 Bear Case
Gross margins compressed 400 bps in Q4 to 44.6%. The company is being squeezed from both ends: higher supply chain costs (tariffs) and the necessity of elevated promotional spending to move inventory.
The company absorbed an astounding $885.8M in non-cash asset impairment charges in FY26. This signals that management has structurally written down the long-term cash generation power of its brand portfolio.
⚖️ Verdict: 🔴
Bearish. While revenue declines are bottoming out, the quality of earnings is deteriorating. The structural damage from tariffs and the necessity to discount products to stimulate demand will restrict profit recovery throughout FY27.
Key Themes
Tariffs Trigger Gross Margin Collapse
The impact of trade policies hit with full force in Q4. Gross margins plummeted from 48.6% to 44.6% YoY, driven primarily by tariffs and less favorable inventory obsolescence. Fiscal 2026 cash flow absorbed ~$72M in tariff-related outflows, directly contradicting the narrative that the company's aggressive supply chain diversification is already insulating the bottom line.
Massive Intangible Write-Downs Continue
The company booked another $79.2M non-cash asset impairment charge in Q4, bringing the FY26 total to a staggering $885.8M. Management attributes this to a sustained decline in the stock price, but it reflects a deeper structural write-down of the future cash-generating power of their acquired and core brands.
Macro Pressures Squeeze Discretionary Spend
The macroeconomic picture remains bleak for Helen of Troy. Lower replenishment orders from retailers and soft consumer demand heavily dragged down the insulated beverageware and prestige hair care categories. Customers are pulling back on non-essential, higher-ticket items.
Aggressive Sourcing Diversification
To combat the relentless tariff pressure, management is executing a multi-year pivot away from China. The goal is to reduce the cost of goods sold exposed to China tariffs to just 15%-20% by the end of FY27, which they expect will cap the net operating income impact to less than $10M for the full year.
Olive & June Growth Pillar
The Olive & June acquisition remains the standout operational bright spot. The brand contributed a 3.3% inorganic boost to Beauty & Wellness net sales in Q4, acting as a critical counterweight against organic business declines of 8.9% in the segment.
Balance Sheet De-leveraging
Despite margin compression, the company reduced its total debt from $916.9M in FY25 to $780.8M in FY26. Post-quarter, the $82M sale of the Southaven, Mississippi distribution facility will be directly funneled into repaying the credit facility, significantly aiding the goal of dropping net leverage to 3.2x by FY27.
Technical Packs and Thermometers Outperform
In a quarter marred by broad-based volume declines, specific product categories bucked the trend. Strong demand for Osprey technical, travel, and lifestyle packs, alongside a sharp increase in thermometer sales within the Wellness portfolio, provided much-needed pockets of growth.
Other KPIs
A major positive. Up from $83.1M in FY25. Strict working capital management offset massive GAAP net losses and a $72M headwind from higher tariff payments, allowing the company to aggressively pay down debt.
Unfavorable operating leverage and increased annual incentive compensation drove SG&A up 270 basis points YoY from 35.9%. The inclusion of the Olive & June cost structure and $4.4M in EPA compliance costs further inflated expenses.
Guidance
Stable. The midpoint of $1.786 billion implies exactly 0.0% growth over FY26's $1.786 billion. This signals an end to the severe top-line contraction seen in FY26, but assumes conservative retailer inventory management and continued promotional pressure.
Decelerating. The midpoint of $3.50 implies a 1.4% decline from FY26's $3.55. The new CEO's 'growth-first mindset' requires a 40 bps increase in strategic investments, which will constrain bottom-line recovery in the near term.
Accelerating slightly. The midpoint of $193.5M represents roughly 4.1% growth over FY26's $185.8M. This suggests that while depreciation/amortization and strategic investments will drag EPS, core operational cash profitability is expected to marginally improve.
Decelerating. A step down from FY26's $131.9M. This contraction is driven by an expectation to maintain working capital efficiency without the massive inventory liquidation benefits realized in prior quarters, alongside $28-$32M in planned capital expenditures for innovation.
Key Questions
Gross Margin Recovery Timeline
Gross margins fell 400 bps in Q4. Given the ongoing shift of production out of China, what is the timeline and structural capability to return gross margins to the historical >47% range?
Promotional Environment Strategy
With the outlook explicitly modeling an 'increasingly competitive and promotional landscape,' how much of the $190-$197M EBITDA guidance is reliant on price hikes versus sheer cost-cutting?
Beauty & Wellness Core Portfolio
Olive & June successfully masked deep organic declines (-8.9%) in Beauty & Wellness. Are there plans to divest legacy brands in this segment that continue to suffer from consumer trade-down?